数据链接：
官方服务：
资源简介：
Clinical characteristics of B-ALL patients.
应用场景：
创建时间：
2019-08-22
相关数据集
An instructive role for IL7RA in the development of human B-cell precursor leukemia
10X single cell analysis of human leukemia, pre-leukemia and normal control. The leukemia was developed in xenograft mice that was serialy transplanted with cells from primary mouse that was transplan
NIAID Data Ecosystem40
Super-enhancer reprogramming drives a B cell-epithelial transition and high-risk leukemia. Mus musculus
IKAROS is required for the differentiation of highly proliferative pre-B cell precursors and loss-of-IKAROS function indicates poor prognosis in precursor B-cell acute lymphoblastic leukemia (B-ALL).
NIAID Data Ecosystem30
The PAX5-JAK2 translocation acts as a dual-hit mutation that promotes aggressive B-cell leukemia via nuclear STAT5 activation
While PAX5 is an important tumor suppressor in B-ALL, it is also involved in oncogenic translocations coding for PAX5 fusion proteins. PAX5-JAK2 encodes a protein consisting of the PAX5 DNA-binding re
NIAID Data Ecosystem20
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation [RNA-Seq]. Mus musculus
Down syndrome (DS) confers a 20-fold increased risk of B cell acute lymphoblastic leukemia (ALL), yet the mechanisms underlying this association are undefined. We show that triplication of only 31 gen
NIAID Data Ecosystem40
Modeling PAX5P80R mutation reveals Hif2a as a common oncogenic relay in B-cell acute lymphoblastic leukemia
The transcription factor PAX5 is a major target of genetic alterations in human B-cell precursor acute lymphoblastic leukemia (B-ALL). Among the alterations, the P80R mutation affecting the DNA-bindin
NIAID Data Ecosystem20
